Grant Bogle reports a stock award at Immuneering
By AlphaYouPublished Form 4
Bogle Grant C.
Reporting filer
Grant Bogle reports a stock award, not an open-market purchase or sale, in Immuneering Corp. Form 4 filed Nov 9, 2026 lists 1 entry.
- Disclosed
- Nov 9, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (derivative) | Bogle Grant C. | 2026-11-09 | A | Grant or award | 66700 | 0 | 66,700 | 0 days | Filed terms
|
Stock Option (derivative)
- Owner
- Bogle Grant C.
- Date
- 2026-11-09
- Code
- A
- Action
- Grant or award
- Quantity
- 66700
- Price
- 0
- Following holdings
- 66,700
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Stock Option
- conversion Or Exercise Price: 3.65
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 66700
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-09
- underlying Security Title: Class A Common Stock
- underlying Security Shares: 66700
- shares Owned Following Transaction: 66700
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bogle Grant C.: Director.
- F1: The option vests and becomes exercisable in equal monthly installments over a three year period commencing on December 9, 2026, and will be fully vested and exercisable on November 9, 2029.
Original sources
Prepared automatically from public filing data. Report a correction.